Instillido (Lidocaine Hydrochloride)

Lidocaine hydrochloride blocks voltage‑gated sodium channels on nerve cells, preventing the rapid influx of sodium that is required for depolarisation. This inhibition stops the generation and propagation of nerve impulses, producing a localized loss of sensation in the area where it is applied.

The dose of Instillido is determined by the prescribing clinician based on the specific procedure, patient characteristics, and clinical judgement. No fixed regimen is provided here; the prescriber will decide the appropriate volume and concentration for each individual case.

Safety data for lidocaine hydrochloride in pregnancy are limited, and the product should only be used when clearly needed. During breastfeeding, lidocaine may be excreted in milk, so caution is advised and the benefits should be weighed against potential risks.

To request Instillido, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Instillido contains lidocaine, an amide‑type local anesthetic with a rapid onset and moderate duration, which is widely used for urethral procedures. Compared with ester‑type agents, lidocaine generally offers a more predictable safety profile and fewer allergic reactions, making it a common first‑choice option.

Instillido should be stored at ambient temperature, preferably below 25 °C, in its original sealed container. Protect the product from moisture, direct sunlight and extreme temperature fluctuations to maintain its stability and sterility.

Instillido is administered directly into the urethra as a sterile solution. The prescriber instills the appropriate volume using a catheter or syringe, allowing the medication to coat the urethral mucosa and produce local anaesthesia before the intended procedure.

Serious risks include systemic lidocaine toxicity, which can manifest as dizziness, tinnitus, seizures, or cardiac arrhythmias, and severe allergic reactions such as rash, swelling, or anaphylaxis. Immediate medical attention is required if any of these symptoms occur.

Instillido should be avoided in patients with a known hypersensitivity to lidocaine or other amide‑type local anesthetics, in those with severe cardiac conduction disorders, and in individuals where the risk of systemic toxicity cannot be adequately monitored.